Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals Inc. (AGIO)

Market Closed
10 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
33. 64
-0.99
-2.8588%
Pre Market
$
34. 50
+0.86 +2.5565%
2B Market Cap
- P/E Ratio
- Div Yield
720,218 Volume
- Eps
$ 34.63
Previous Close
Add Transaction
Day Range
33.21 35.28
Year Range
22.24 46
Want to track AGIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Agios Pharmaceuticals Inc. (AGIO) Statistics

Valuation metrics

Market Cap 2B
Enterprise value 1.91B
Trailing P/E (ttm) -4.72
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 20.1
Price/Book (mrq) 1.92
Enterprise Value/Revenue 19.4
Enterprise Value/EBITDA -4.58

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 318.64K
Average volume (90 days) 1.44M

Price summary

52-Week low 22.24
52-Week high 46
Beta -
50-Day moving average 34.2
200-Day moving average 30.98

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -4.18%
Operating margin -4.67%

Operational effectiveness

Return on assets -0.37%
Return on equity -0.36%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.65
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.91
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 10.38
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 10.22%
Book value per share (mrq) 17.25

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -